DMEMEDS shared post via Reuters: U.S. FDA approves Biogen's hemophilia A drug Eloctate

WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Biogen Idec Inc's long-lasting hemophilia A drug, Eloctate, adding another product to the company's nascent portfolio of drugs for non-malignant blood disorders. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/8EgzL8m1E-A/story01.htm

Read More